Effect of IV Ferric Carboxymaltose on HR-QoL in Iron-Deficient Patients With Acute Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Effect of Intravenous Ferric Carboxymaltose on Health-Related Quality of Life in Iron-Deficient Patients With Acute Heart Failure: The Results of the AFFIRM-AHF Study
Eur Heart J 2021 Jun 03;[EPub Ahead of Print], EA Jankowska, BA Kirwan, M Kosiborod, J Butler, SD Anker, T McDonagh, M Dorobantu, J Drozdz, G Filippatos, A Keren, I Khintibidze, H Kragten, FA Martinez, M Metra, D Milicic, JC Nicolau, M Ohlsson, A Parkhomenko, DA Pascual-Figal, F Ruschitzka, D Sim, H Skouri, P van der Meer, BS Lewis, J Comin-Colet, S von Haehling, A Cohen-Solal, N Danchin, W Doehner, HJ Dargie, M Motro, T Friede, V Fabien, F Dorigotti, S Pocock, P PonikowskiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.